Cite
Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion.
MLA
Lu, Junli, et al. “Myeloid-Derived Suppressor Cells in Cancer: Therapeutic Targets to Overcome Tumor Immune Evasion.” Experimental Hematology & Oncology, vol. 13, no. 1, Apr. 2024, pp. 1–24. EBSCOhost, https://doi.org/10.1186/s40164-024-00505-7.
APA
Lu, J., Luo, Y., Rao, D., Wang, T., Lei, Z., Chen, X., Zhang, B., Li, Y., Liu, B., Xia, L., & Huang, W. (2024). Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion. Experimental Hematology & Oncology, 13(1), 1–24. https://doi.org/10.1186/s40164-024-00505-7
Chicago
Lu, Junli, Yiming Luo, Dean Rao, Tiantian Wang, Zhen Lei, Xiaoping Chen, Bixiang Zhang, et al. 2024. “Myeloid-Derived Suppressor Cells in Cancer: Therapeutic Targets to Overcome Tumor Immune Evasion.” Experimental Hematology & Oncology 13 (1): 1–24. doi:10.1186/s40164-024-00505-7.